Physician profile
Vikrant Donthamsetti
NPI 1871895110
$4,038.11
in general payments reported to CMS, 2019-2025
12 companies · $306 in 2025
The $306 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.67 · 2020: $27.07 · 2021: $30.50 · 2022: $137 · 2023: $166 · 2024: $3,338 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,812 · Food and Beverage: $1,118 · Travel and Lodging: $879.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,812.00 |
| Food and Beverage | $1,118.13 |
| Travel and Lodging | $879.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,812.00 | 2024 | Scoutpro Osmolarity System |
| Alcon Vision LLC | $1,299.84 | 2019-2024 | Clareon |
| Glaukos Corporation | $539.30 | 2024-2025 | Idosetr, Idose, Istent Trabecular Micro-Bypass System Model Is3 |
| Sight Sciences, INC. | $140.63 | 2022-2024 | Omni Surgical System |
| Amgen INC. | $70.56 | 2025 | Tepezza |
| Abbvie INC. | $61.61 | 2022-2025 | Durysta |
| Rayner Intraocular Lenses Limited | $23.31 | 2024 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Tearlab Corp | $22.62 | 2024 | Scoutpro Osmolarity System |
| Thea Pharma INC. | $21.99 | 2023 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $16.44 | 2021 | |
| New World Medical,INC. | $15.75 | 2019 | |
| Allergan, INC. | $14.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikrant Donthamsetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.